178 related articles for article (PubMed ID: 28382143)
1. Albumin-to-Alkaline Phosphatase Ratio: A Novel Prognostic Index of Overall Survival in Cisplatin-based Chemotherapy-treated Patients with Metastatic Nasopharyngeal Carcinoma.
Nie M; Sun P; Chen C; Bi X; Wang Y; Yang H; Liu P; Li Z; Xia Y; Jiang W
J Cancer; 2017; 8(5):809-815. PubMed ID: 28382143
[TBL] [Abstract][Full Text] [Related]
2. The Prognostic Value of Albumin-to-Alkaline Phosphatase Ratio before Radical Radiotherapy in Patients with Non-metastatic Nasopharyngeal Carcinoma: A Propensity Score Matching Analysis.
Kim JS; Keam B; Heo DS; Han DH; Rhee CS; Kim JH; Jung KC; Wu HG
Cancer Res Treat; 2019 Oct; 51(4):1313-1323. PubMed ID: 30699498
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Value of the Albumin-to-Alkaline Phosphatase Ratio before Chemoradiotherapy in Patients with Nonmetastatic Nasopharyngeal Carcinoma.
Yang L; Gao J; Zhou Y; Tao Z; He J; Yang J; Wang R; Zhang Y; Huang Y; Zhou L; Sun B
Chemotherapy; 2021; 66(1-2):40-46. PubMed ID: 33601377
[TBL] [Abstract][Full Text] [Related]
4. Pretreatment serum albumin-to-alkaline phosphatase ratio is an independent prognosticator of survival in patients with metastatic gastric cancer.
Li YT; Zhou XS; Han XM; Tian J; Qin Y; Zhang T; Liu JL
World J Gastrointest Oncol; 2022 May; 14(5):1002-1013. PubMed ID: 35646278
[TBL] [Abstract][Full Text] [Related]
5. Albumin-to-Alkaline Phosphatase Ratio as an Independent Prognostic Factor for Overall Survival of Advanced Hepatocellular Carcinoma Patients without Receiving Standard Anti-Cancer Therapies.
Cai X; Chen Z; Chen J; Ma X; Bai M; Wang T; Chen X; Wu D; Wei L; Li X; Lin Q; Wen J; Ruan D; Lin Z; Dong M; Wu X
J Cancer; 2018; 9(1):189-197. PubMed ID: 29290785
[No Abstract] [Full Text] [Related]
6. Albumin-to-alkaline phosphatase ratio at diagnosis predicts survival in patients with metastatic non-small-cell lung cancer.
Li D; Yu H; Li W
Onco Targets Ther; 2019; 12():5241-5249. PubMed ID: 31303770
[No Abstract] [Full Text] [Related]
7. Prognostic impact of the pretreatment albumin to alkaline phosphatase ratio for nonmetastatic breast cancer patients.
Long ZQ; Hua X; Zhang WW; Lv SW; Deng JP; Guo L; He ZY; Lin HX
Cancer Manag Res; 2019; 11():4809-4814. PubMed ID: 31213902
[No Abstract] [Full Text] [Related]
8. The Predictive Value of Albumin-to-Alkaline Phosphatase Ratio for Overall Survival of Hepatocellular Carcinoma Patients Treated with Trans-Catheter Arterial Chemoembolization Therapy.
Chen ZH; Zhang XP; Cai XR; Xie SD; Liu MM; Lin JX; Ma XK; Chen J; Lin Q; Dong M; Wu XY; Wen JY; Xu RH
J Cancer; 2018; 9(19):3467-3478. PubMed ID: 30310503
[No Abstract] [Full Text] [Related]
9. Validation of the Prognostic Value of Preoperative Albumin-to-Alkaline Phosphatase Ratio in Patients with Surgically Treated Non-Metastatic Renal Cell Carcinoma.
Hu X; Yang ZQ; Dou WC; Shao YX; Wang YH; Lia T; Li X
Onco Targets Ther; 2020; 13():8287-8297. PubMed ID: 32903862
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Value of Albumin-to-Alkaline Phosphatase Ratio for
Gan Y; Ren J; Xian J; Yu H; Jin J; Li D; Li W
Int J Gen Med; 2022; 15():3405-3416. PubMed ID: 35378914
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of the albumin-to-alkaline phosphatase ratio on urologic outcomes in patients with non-metastatic renal cell carcinoma following curative nephrectomy.
Xia A; Chen Y; Chen J; Pan Y; Bao L; Gao X
J Cancer; 2019; 10(22):5494-5503. PubMed ID: 31632493
[No Abstract] [Full Text] [Related]
12. Albumin-to-alkaline phosphatase ratio serves as a prognostic indicator in unresectable pancreatic ductal adenocarcinoma: a propensity score matching analysis.
Zhang K; Dong S; Jing YH; Gao HF; Chen LY; Hua YQ; Chen H; Chen Z
BMC Cancer; 2020 Jun; 20(1):541. PubMed ID: 32517802
[TBL] [Abstract][Full Text] [Related]
13. Albumin-to-alkaline phosphatase ratio as a novel prognostic indicator for patients undergoing minimally invasive lung cancer surgery: Propensity score matching analysis using a prospective database.
Li SJ; Lv WY; Du H; Li YJ; Zhang WB; Che GW; Liu LX
Int J Surg; 2019 Sep; 69():32-42. PubMed ID: 31319230
[TBL] [Abstract][Full Text] [Related]
14. The prognostic value of the preoperative albumin to alkaline phosphatase ratio in patients with non-small cell lung cancer after surgery.
Zhang L; Zhang H; Yue D; Wei W; Chen Y; Zhao X; Zhu J; Zhang B; Zhang Z; Wang C
Thorac Cancer; 2019 Jul; 10(7):1581-1589. PubMed ID: 31161711
[TBL] [Abstract][Full Text] [Related]
15. Albumin-To-Alkaline Phosphatase Ratio as a Novel and Promising Prognostic Biomarker in Patients Undergoing Esophagectomy for Carcinoma: A Propensity Score Matching Study.
Zhu X; Chen D; Li S; Zhang W; Li Y; Wang X; Zhou J; Wen Z
Front Oncol; 2021; 11():764076. PubMed ID: 34746006
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Value of Albumin-to-Alkaline Phosphatase Ratio in Hepatocellular Carcinoma Patients Treated with Liver Transplantation.
Li H; Wang L; Chen L; Zhao H; Cai J; Yao J; Zheng J; Yang Y; Wang G
J Cancer; 2020; 11(8):2171-2180. PubMed ID: 32127944
[No Abstract] [Full Text] [Related]
17. Albumin-to-Alkaline Phosphatase Ratio: Does It Predict Survival in Grade 1 and Grade 2 Neuroendocrine Tumors?
Acikgoz Y; Bal O; Dogan M
Pancreas; 2021 Jan; 50(1):111-117. PubMed ID: 33370032
[TBL] [Abstract][Full Text] [Related]
18. Albumin-to-alkaline phosphatase ratio: A novel prognostic index for patients with driver mutation-negative advanced non-small cell lung cancer.
Liu X; Li Y; Zhao Q; Jiang H; Ni J; Cai H
Clin Respir J; 2021 May; 15(5):540-549. PubMed ID: 33565707
[TBL] [Abstract][Full Text] [Related]
19. The impact of serum albumin-to-alkaline phosphatase ratio in cervical cancer patients treated with definitive chemoradiotherapy.
Onal C; Gultekin M; Yavas G; Oymak E; Yuce Sari S; Guler OC; Yigit E; Yildiz F
J Obstet Gynaecol; 2022 Aug; 42(6):2426-2432. PubMed ID: 35653776
[TBL] [Abstract][Full Text] [Related]
20. Albumin-to-alkaline phosphatase ratio: A novel prognostic index of overall survival in cholangiocarcinoma patients after surgery.
Xiong JP; Long JY; Xu WY; Bian J; Huang HC; Bai Y; Xu YY; Zhao HT; Lu X
World J Gastrointest Oncol; 2019 Jan; 11(1):39-47. PubMed ID: 30984349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]